The impermeability barrier provided by the outer membrane of enteric bacteria, a feature lacking in Gram-positive bacteria, plays a major role in maintaining resistance to numerous antimicrobial compounds and antibiotics. Here we demonstrate that mutational inactivation of spr, coding for a muramyl endopeptidase, significantly sensitizes Salmonella enterica serovar Typhimurium to vancomycin without any accompanying apparent growth defect or outer membrane destabilization. A similar phenotype was not achieved by deleting the mepA, pbpG, nlpC, yebA or yhdO genes coding for functional homologues to Spr. The spr mutant revealed increased autolytic behavior in response to not only vancomycin, but also to penicillin G, an antibiotic for which the mutant displayed a wild-type MIC. A screen for suppressor mutations of the spr mutant phenotype revealed that deletion of tsp (prc), encoding a periplasmic carboxypeptidase involved in processing Spr and PBP3, restored intrinsic resistance to vancomycin and reversed the autolytic phenotype of an spr mutant. Our data suggest that Spr contributes to intrinsic antibiotic resistance in S. Typhimurium without directly affecting the outer membrane permeability barrier. Furthermore, our data suggests that compounds that target specific cell wall endopeptidases might have the potential to expand the activity spectrum of traditional Gram-positive antibiotics.
INTRODUCTION
Peptidoglycan (murein) constitutes a main component of the bacterial cell wall. It is composed of repeated N-actetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) disaccharide units, cross-linked by peptide bridges. The synthesis of this mesh in turn is the target of several classes of antibiotics, such as the β -lactams and glycopeptides. The outer membrane of Gram-negative enteric bacteria, due to its relative impermeability, provides an intrinsic resistance barrier against many large molecular compounds, including selected antibiotics such erythromycin (Delcour 2009; Nikaido and Vaara 1985) , novobiocin (Anderle et al. 2008) , rifampicin and the glycopeptide vancomycin (Krishnamoorthy et al. 2013; Weeks et al. 2010) .
Peptidoglycan maintains bacterial shape, septum formation at the point of cell division, and cell integrity upon internal turgor stress. To accomplish this, peptidoglycan not only needs to assemble, but also disassemble, in order to facilitate changes in size and outline of the cell wall in growing bacteria. In this, several periplasmic amidases, endopeptidases and glycosylases participate together with penicillinbinding proteins (PBPs), themselves transpeptidases, to shape the peptidoglycan (Sauvage et al. 2008) . While the PBPs have the major responsibility of catalyzing the formation of interpeptide bridges between overlapping GlcNAc-MurNAc polymers, the murein endopeptidases are tasked with cleaving interpeptide bridges to facilitate incorporation of new GlcNAC-MurNAc polymers into the growing peptidoglycan mesh. The importance of correctly balancing these opposing activities is illustrated by the fact that blocking PBP activity with β-lactams results in autolysis in Escherichia coli (Prestidge and Pardee 1957) .
The increasing frequency of clinical bacterial isolates producing extended-spectrum β-lactamases is limiting the effectiveness of antibiotics that target cell wall synthesis amongst Gram-negative species (Coque, Baquero, and Canton 2008) . The search for new antibiotics to treat Gram-negative bacterial infections would be advanced by a better understanding of bacterial cell wall homeostasis at the level of peptidoglycan. Because it is a genetically amenable bacterium, E. coli has been the main focus for studies on the activities of cell wallmodulating enzymes. From these studies a consensus has emerged that, apart from PBP3 (Botta and Park 1981) , each of the glycolytic, endopeptic hydrolases and PBPs are individually dispensable for bacterial viability. Accordingly, inactivation of any one (or sometimes more than one) of the genes encoding these enzymes (PBP4: (Denome et al. 1999; Michio Matsuhashi et al. 1977; Meberg et al. 2004) , PBP5: (Denome et al. 1999; M Matsuhashi et al. 1979; Nishimura et al. 1980; Spratt 1980) , PBP6: (Denome et al. 1999; Broome-Smith and Spratt 1982) , PBP6b: (Baquero et al. 1996) , PBP7/PBP8: (Denome et al. 1999; Henderson, Templin, and Young 1995) , reviewed in: (van Heijenoort 2011)) does not prevent bacterial growth under laboratory conditions. While this might imply a high degree of functional redundancy, it does not exclude the possibility that some or all of these enzymes may have unique functions under other more specific conditions. A recent study (Singh et al. 2012 ) confirmed muramyl endopeptidase activity for three additional E. coli proteins; Spr, YebA and YdhO, renamed in E. coli to MepS, MepM and MepH (Singh et al. 2015) . More specifically the study presented data implying that Spr or YebA might represent endopeptidases with less redundant functions in that it was feasible to construct an Δ sprΔyebA mutant only in an E. coli strain genetically complemented with spr (mepS) (Singh et al. 2012) .
Salmonella enterica serovar Typhimurium (S. Typhimurium) is a Gramnegative enterobacterium with an increasing antibiotic resistance development in its genus (Klemm et al. 2018; Hong et al. 2016; Angelo et al. 2016) . As the S. Typhimurium genome includes genes with high sequence similarity to the mepS, mepM and mepH genes of E. coli, and given the potential importance of mepS and mepM for viability of E. coli (Singh et al. 2012) , we studied the phenotypes of S. Typhimurium mutants in which these genes were deleted, either singly or in combination. We characterized Δ spr, Δ yebA and Δ ydhO mutants in terms of their growth and susceptibility profiles against antimicrobials, and in addition Δ spr for autolytic behavior. Our findings highlight Spr as a possible new target for antibacterial treatment in order to sensitize Salmonella against Gram-positive-specific antibiotics. Growth characteristics of mutants. In agreement with observations made in E. coli (Singh et al. 2012) none of the single deletion mutants revealed any significant difference in the overall shape of their growth curves ( Fig. 1A and 1B ). All single mutants had a similar logarithmic growth rate, and reached a similar optical density in stationary phase in both LB and TY medium. Even the Δ yebAΔydhO mutant grew like the wild type parental strain. On the other hand, the Δ sprΔyebA mutant showed a somewhat decreased rate of replication in TY medium at later stages of the growth slope ( Fig. 1B) . Still, taken together, these findings suggest a high degree of redundancy for the Spr, YebA and YhdO endopeptidases in S. Typhimurium regarding growth in broth cultures. Antibiotic and detergent sensitivities. As peptidoglycan turnover and outer membrane synthesis in E. coli appear connected (Gray et al. 2015) , and as E. coli mutants simultaneously lacking several murein hydrolases show evidence of an outer membrane permeability barrier defect (Heidrich et al. 2002) , we assessed whether any of the murein endopeptidases Spr, YebA or YhdO were needed for maintaining the outer membrane permeability barrier in S. Typhimurium. To achieve this, we screened the panel of our S. Typhimurium endopeptidase mutants for possible sensitization to six different antibiotics using the disc diffusion method, as well as for detergent tolerance. The antibiotics tested were penicillin G, polymyxin B, tetracycline, rifampicin, novobiocin, and vancomycin, the latter three for which wild-type S. Typhimurium is intrinsically resistant to due to the outer membrane permeability barrier (Sukupolvi et al. 1984) . As comparator strains we used wild-type S. Typhimurium SR-11, and three isogenic LPS mutants expected to have an outer membrane permeability defect (Sukupolvi et al. 1984) . Sensitivity testing was conducted using low osmolarity TY medium. The rationale for this was that high salt concentrations reduce the sensitivity of E. coli to selected antibiotics (Beggs and Andrews 1976) , and that low osmolarity medium would favor expression of the more permeable outer membrane porin OmpF (Jaffe, Chabbert, and Semonin 1982; Harder, Nikaido, and Matsuhashi 1981) , thus increasing the probability of detecting any sensitization.
RESULTS

Construction
Figure 2. Detergent sensitivity and membrane protein profile of muramyl endopeptidase mutants. (A)
For probing detergent sensitivity 10 5 bacteria of each strains was incubated in 0.5% DOC for 30 min, where after the bacterial viable colonies were enumerated. Results are presented as relative CFU yield in relation to the wild-type. The graph shows the mean value and the standard error of the mean of three independent replicates. Statistical test was an one-way ANOVA with Dunnett's correction for multiple comparisons when comparing the mutants to the wild type. (B) SDS-PAGE gel revealing the outer membrane protein profiles of the wild-type and mutant strains. The positions of prestained molecular weight markers are indicated at the right. The standard used is PageRuler Prestained Protein Ladder (#26616, Thermo Scientific).
As compared to the wild type the three LPS mutants, Δ rfaC (waaC), Δ rfaG (waaG), and Δ rfaP (waaP) were each sensitized to polymyxin B, novobiocin, rifampicin and vancomycin, but not to tetracycline (Table  1) . The Δ spr mutant was strongly sensitized to vancomycin (inhibition zone increased from 0 to 13mm), but not to the other antibiotics tested. The vancomycin sensitization was confirmed using MIC determinations (Table 1) . Subsequent MIC determinations demonstrated that the intrinsic vancomycin resistance was reduced 8-fold for the Δ spr mutant and 32-fold for the Δ sprΔyebA mutant (Table 1) . Also, the Δ sprΔyebA mutant revealed a moderate sensitization to novobiocin, penicillin G and rifampicin, while the sole Δ yebA mutant did not reveal any increase in sensitization to any of the antibiotics included, when compared to the wild type (Table 1) .
Any sensitization to the detergent deoxycholate (DOC) of the Δ spr and Δ sprΔyebA mutants was evaluated by incubating them in 0.5% DOC for 30 minutes. In this assay only the Δ sprΔyebA mutant revealed a clear sensitization to DOC exposure ( Fig. 2A) . These results implied that a plain Δ spr mutation in S. Typhimurium SR-11 associates with significant sensitization to vancomycin without revealing a general defect in the outer membrane permeability barrier, while addition of the Δ yebA mutation evidently caused an outer membrane destabilization.
Selectivity of Spr in maintaining intrinsic vancomycin resistance.
As the antibiotic sensitization profile caused by the Δ spr mutation was unexpected, we next tested whether this mutant phenotype was restricted to the SR-11 line of S. Typhimurium. Hence, the Δ spr mutation was introduced into the commonly used laboratory S. Typhimurium lines SL1344 and 14028. When tested for vancomycin tolerance, the MIC for the wild type SL1344 and 14028 strains was the same as for the wild type SR-11 line (100 μ g/ml), whereas in the corresponding SL1344 and 14028 Δ spr mutant strains the MIC decreased to 12.5 μ g/ml, equaling that of the SR-11 Δ spr mutant (Table  1) .
In E. coli overproduction of PBP7 suppresses thermosensitive growth associated with a mepS mutation (Hiroshi Hara et al. 1996) , suggesting that PBP7 and MepS connect in parallel pathways. Hence, we deleted pbpG, coding for the PBP7 homologue in S. Typhimurium. We also created deletion mutants for the mepA and nlpC homologues in S. Typhimurium, each coding for endopeptidases functionally related to Spr. Yet, none of the three additional mutants showed sensitization to the antibiotics included in the test panel (Table 1) .
In E. coli, overexpression of selected outer membrane porin proteins can result in an outer membrane permeability defect (Krishnamoorthy et al. 2016) . We compared outer membrane protein profiles of the wild type, Δ spr and Δ sprΔyebA mutants on SDS-PAGE gels. We did not observe any significant difference in outer membrane protein profile for the mutants as compared to the wild type ( Fig. 2B ), arguing that the increased vancomycin sensitization is not caused by a major in outer membrane protein composition. Our observations combined show that deletion of sp Typhimurium is associated with sensitization to vancomycin this sensitization is not restricted to line SR-11. Furthermore that the lack of muramyl endopeptidases YebA, YdhO, PBP7, NlpC as such do not result in sensitization to vancomycin, no spr deletion associate with a general overproduction of ma proteins.
Genetic verifications implicate a catalytically active Sp maintainer of intrinsic vancomycin tolerance in S. Typh
To further ensure the PCR-based confirmations of the Δ sprΔyebA mutations we performed whole genome sequenci two mutant constructs, which verified their expected genetic composition. To exclude any potential polar effects of the verified Δ spr deletions as a cause of vancomycin sensitization, we applied genetic complementation. We cloned the spr gene from S. Typhimurium SR-11 under the control of the arabinose-inducible promoter in the plasmid vector pBAD30. We next generated a point mutation in this plasmid replacing the codon for the conserved catalytic Spr cysteine residue with a codon for serine, creating a C70S alteration in the mature protein (Aramini et al. 2008; Singh et al. 2012) . Introducing the cloned native spr gene into either the Δ spr or Δ sprΔyebA mutant fully restored vancomycin resistance, whereas both the empty pBAD30 vector, and the plasmid coding for a catalytically inactive Spr variant, did not restore vancomycin resistance (Fig. 3 ). We conclude that intrinsic vancomycin resistance of S. Typhimurium requires a catalytically active Spr. Effect of the Δ spr deletion on antibiotic-induced autolysis. Penicillin G activates in E. coli a protein-synthesis-dependent autolysis (Prestidge and Pardee 1957) . Hence, we set out to test whether the Δ spr mutation would affect any autolytic behavior of S. Typhimurium in response to cell wall synthesis inhibitors. To enable quantification of bacterial cell lysis, we adapted a β-galactosidase (LacZ) release assays (detailed in Material and Methods). In this we incubated a logarithmic growth phase culture of S. Typhimurium with increasing concentrations of a cell wall synthesis inhibitor for 1 hour, after which the β-galactosidase activities were determined from the culture supernatants. Both the wild-type and Δ spr mutant revealed an increased level of β-galactosidase release as a function of increased concentration of vancomycin, with the release being more pronounced for the Δ spr mutant (Fig. 4A ).
To confirm that the vancomycin induced lysis depended on active protein synthesis we repeated the experiments with tetracycline added into the reaction mixture, as the wild-type and the Δ spr mutant exhibited identical MIC for tetracycline (Table 1) . Adding tetracycline blocked the release of β-galactosidase from both strains (Fig. 4B ).
As wild type S. Typhimurium SR-11 and the Δ spr mutant had an equal MIC for penicillin G (Table 3) , we next repeated the lysis assay by replacing vancomycin with penicillin G. Both the wild-type and Δ spr mutant reached a similar plateau level of β-galactosidase release at a higher concentration range of penicillin G (Fig. 5A ). However, compared to the wild-type, the β-galactosidase release was more pronounced for the Δ spr mutant at concentrations below the determined 6.25 μ g/ml MIC for penicillin G (t-test: p < 0.01 for 2 and 4 μ g/ml when comparing Δ spr mutant to wild-type). Yet again, as for vancomycin, the β-galactosidase release by penicillin G was blocked by addition of tetracycline ( Fig. 5B ).
When we followed the development of the optical density (OD 600nm ) under the 1 hour incubation with cell wall synthesis inhibitors ( Fig. 4D and Fig. 5D ), we noted that a substantial proportion of the bacteria apparently remained unlysed. When we determined the viable count from cultures exposed to 200 μ g/ml of vancomycin, representing 2-fold MIC for wild-type and 8-fold MIC for Δ spr mutant bacteria, we recovered a substantial residual amount of viable bacteria from the cultures (Fig. 4E ). When the viable counts were measured for the penicillin G exposed cultures (containing antibiotic 6 times the MIC), we could barely detect any viable bacteria (Fig. 5E ).
The
Δ sprΔyebA mutant exhibited a substantial decrease in tolerance to both vancomycin and penicillin MIC as compared to either the wildtype or Δ spr mutant (Table 1 ). This increased sensitivity was associated with a significantly higher level of β-galactosidase release (relative to the wild-type or the Δ spr mutant) after exposure to either antibiotic for 1 hour.
Combined these data demonstrate that vancomycin induce a proteinsynthesis-dependent autolysis in S. Typhimurium, and that intensity of this autolysis inversely correlated with the MIC to vancomycin. At the other hand, compared to the wild type, penicillin G evoked a more proficient autolysis in the Δ spr mutant despite the wild-type and Δ spr mutant had the same MIC for penicillin G.
Isolation of Δspr vancomycin-resistant suppressor mutations.
Vancomycin-resistant mutants were selected in the Δ sprΔyebA background using a vancomycin gradient plate (for details, see Materials and Methods). Twelve vancomycin-tolerant Δ sprΔyebA mutants were analysed by whole genome sequencing. Eleven of the mutants carried overlapping deletions covering nucleotides 1,920,000 -1,965,000 in the S. Typhimurium LT2 reference genome ( Fig. 6A ). At the centre of this region is tsp, encoding a periplasmic carboxypeptidase. The remaining suppressor mutant carried a point mutation within tsp itself (Fig. 6A) . These data suggest that inactivation of tsp is the common feature of mutations that suppress the vancomycin sensitivity phenotype of the Δ sprΔyebA mutant. To confirm the tsp mutations as suppressors, we deleted tsp, as well as the individual genes that mapped upstream and downstream of tsp (proQ and htpX) in the Δ sprΔyebA mutant. Out of these three constructs only deletion of tsp resulted in a vancomycin resistant phenotype in the Δ sprΔyebA mutant (Table 1 ). In addition, when the tsp deletion was introduced into the Δ spr mutant it converted the phenotype from vancomycin sensitive to vancomycin resistant (Table 1) . Conversely, when a cloned tsp gene was introduced into the vancomycin resistant Δ sprΔtsp and Δ sprΔyebAΔtsp mutants the phenotypes of each were reverted to vancomycin sensitive (Fig. 6B) .
The
Δ tsp mutation also reverted the general antibiotic sensitization of the Δ sprΔyebA mutant (Table 1 ). In addition, introduction of the tsp deletion into the Δ spr and Δ sprΔyebA mutants suppressed the autolysis by reducing their release of β-galactosidase in the presence of vancomycin or penicillin G ( Fig. 4C and 5C ). Thus, a tsp deletion acted as a general suppressor mutation for Δ spr and Δ sprΔyebA mutant phenotypes. That said, the tsp deletion alone did not confer increased vancomycin resistance (Table 1) .
In E. coli, Tsp co-purifies with the outer membrane lipoprotein NlpI, which assists Tsp in degrading MepS (Spr) (Singh et al. 2015) . Furthermore, nlpI mutations suppress a temperature-sensitive phenotype of an E. coli Δ mepS mutant (Tadokoro et al. 2004 ) implying a functional connection between Tsp, NlpI and MepS. Yet, when we deleted nlpI in the S. Typhimurium Δ spr and Δ sprΔyebA mutants, they retained their sensitization to vancomycin (Table 1 ). Hence the vancomycin-sensitive phenotype of the Δ spr mutant is dependent chiefly only on Tsp rather an on NlpI. 
DISCUSSION
In Gram-negative enteric bacteria, the outer membrane acts as a major barrier contributing to impermeability to large molecular compounds, adding to their intrinsic resistance to antibiotics, such as lysozyme, novobiocin, rifampicin and vancomycin (Grundström, Normark, and Magnusson 1980; Helander et al. 1989) . Accordingly, alterations that disrupt the outer membrane barrier can sensitize enteric bacteria to such compounds (Sukupolvi et al. 1984) . Lipopolysaccharide (LPS) strongly contributes to this outer membrane integrity and mutations in genes involved in LPS biosynthesis, including envA, rfaC (waaC), and rfaP (waaP), sensitize Gram-negative bacteria simultaneously to numerous antimicrobials (Grundström, Normark, and Magnusson 1980; Helander et al. 1989) . Outer membrane integrity can also be disturbed by the expression of aberrant outer membrane proteins (Rhen, O'Connor, and Sukupolvi 1988) , by exposing bacteria to polymyxin B nonapetide (Vaara and Vaara 1983; Ofek et al. 1994 ), a compound which lacks intrinsic bacteriocidal activity, or by a simultaneous genetic depletion of several murein hydrolases (Heidrich et al. 2002) .
In E. coli, mutants lacking the Spr, YebA or YhdO single muramyl endopeptidases have no obvious growth phenotypes (Singh et al. 2012 ). In accordance, we observed that individual genetic deletion of murein endopeptidases Spr, YebA or YhdO in S. Typhimurium did not affect growth of the bacterium in broth cultures. We also created Δ spr, Δ yebA and Δ yhdO double mutants, to test for redundancy in their contribution to S. Typhimurium growth in broth. Specifically for the Δ sprΔyebA mutant, we noted a minor defect in growth capacity. As this phenotype was not seen for the single Δ spr, Δ yebA or Δ yhdO mutants, or in the Δ yebAΔyhdO double mutant, our observations suggested that spr might have a non-redundant function the growth conditions tested.
Previously outer membrane destabilization with accompanying vancomycin sensitivity has been seen in E. coli when deleting several muramyl hydrolases simultaneously (Korsak, Liebscher, and Vollmer 2005) . Our study is the first where depletion of a single muramyl endopeptidase, Spr, results in vancomycin sensitization. Significantly, the vancomycin sensitization associated with the Δ spr mutation did not associate with sensitization to rifampicin or novobiocin, which would be expected in the case of classical outer membrane destabilization. This implies that there might be an alternative pathway for outer membrane leakage in an Spr-deficient strain. This alternative pathway could involve an increased propensity for autolysis in bacteria lacking Spr, which itself could cause a form of cell wall destabilization. In support of this we could correlate increased autolytic behaviour upon exposure to vancomycin, measured as release of the cytoplasmic β-galactosidase enzyme. Using this assay, the Δ spr mutant also revealed a more rapid onset of autolytic behaviour upon exposure to penicillin G, despite the fact that the wild-type and Δ spr mutant shared the same MIC for penicillin G. Moreover, the Δ spr mutant appeared to undergo autolysis at sub-MIC concentrations of penicillin G.
When recording autolysis by measuring decrease in optical density, we noted that in the bacterial cultures undergoing lysis, exposed either to vancomycin or penicillin G, a significant proportion of each culture remained apparently non-lysed. Also, even at a vancomycin concentration 16-fold MIC, we could recover a substantial proportion of viable Δ spr bacteria at the end of the autolysis experiment. Viable Δ spr bacteria were also recovered from the corresponding penicillin Gexposed cultures but at a 100-fold lower frequency. These results would imply that vancomycin and penicillin G both induce autolysis in the Δ spr mutant, but that in each case there remains a sub-population that is resilient to autolysis, with a substantial proportion of cultivable bacteria remaining 1 hour after vancomycin exposure that exceeds their MIC value. An hypothesis to explain these data is that there is a different proportions of lysis-proficient and non-proficient bacteria in Δ spr mutant and wild-type bacterial cultures. Accordingly, the effect of deleting tsp in the dynamics of autolysis could be that it decreases the proportion of the lysis-proficient bacteria. Whether these non-proficient bacteria would eventually lose their colony-forming ability, or lyse, upon prolonged vancomycin exposure remains to be evaluated.
In Gram-positive bacteria vancomycin resistance is achieved through the acquisition of large genetic blocks coding for new peptidoglycan motifs, rather than through point mutations (Faron, Ledeboer, and Buchan 2016; Gardete and Tomasz 2014) . As the MIC for our vancomycin-sensitive Δ sprΔyebA mutant approached MIC values of susceptible Gram-positive pathogens such as Enterococcus faecalis and Staphylococcus aureus (Susceptible Enterococci spp.
≤ 4 μ g/ml and susceptible S. aureus ≤ 2 μ g/ml according to "EUCAST: Clinical Breakpoints" (http://www.eucast.org)), we set out to probe whether we could in a Gram-negative vancomycin-sensitive bacterium select for spontaneous mutations adding to vancomycin tolerance. In this, we selected and genetically confirmed that Δ spr-mediated vancomycin sensitization, even the more pronounced sensitization of the Δ sprΔyebA mutant, required a tsp-proficient genetic background. The gene tsp itself codes for periplasmic endopeptidase implicated in processing of Spr and PBP3 (Singh et al. 2015; H Hara et al. 1991; H. Hara et al. 1989) . While any corresponding Spr/Tsp machinery does not exist in enterococci, the success of isolating vancomycin resistant mutations, even point mutations, in our Δ sprΔyebA mutant background adds to our understanding of how vancomycin is involved in blocking peptidoglycan synthesis by showing that resistance can be achieved without horizontal gene transfer. We here also demonstrate that intrinsic S. Typhimurium vancomycin resistance relies on a catalytically active Spr. This, and the fact that the vancomycin sensitivities of the Δ spr and Δ sprΔyebA mutants are close to the clinical breakpoints of relevant clinical Gram-positive pathogens places the catalytic activity of Spr as a potential target whose inhibition could potentiate treatment of enteric bacterial infections with vancomycin.
In summary, we have genetically defined a new pathway for intrinsic resistance to the large-molecular-weight antibiotic vancomycin, that is not dependent on outer membrane permeability, in the Gram-negative pathogen S. Typhimurium. This new pathway involves the combined action of the muramyl endopeptidases Spr, together with the protease Tsp, in maintaining the peptidoglycan homeostasis essential for maintaining the cell wall integrity of the bacterium upon antibiotic challenge. These insights add to the knowledge needed to combat the increasing problem of antibiotic resistance in Gram-negative bacteria.
MATERIALS AND METHODS Bacterial strains.
Mutations were constructed in the Salmonella enterica serovar Typhimurium SR-11 background (Sukupolvi et al. 1997) , and are listed in Table S1 . The strains LB5010 (Bullas and Ryu 1983) and ATCC 14028 were used as intermediary hosts in creating mutations. Escherichia coli Top10 and TG1 were used as intermediary hosts during cloning. Furthermore, S. Typhimurium strains ATCC 14028s and SL1344 were also used to host a Δ spr mutation.
Media and growth conditions. Growth media included tryptone and yeast extract (Sigma-Aldrich, 10 g/l respective 5 g/l) with 10 g/l of NaCl (LB medium), or without NaCl (TY medium). Cultures were incubated at 37°C unless otherwise stated. When needed, antibiotics were added to the growth media at the following concentrations: ampicillin 100 μ g/ml; chloramphenicol 25 μ g/ml; kanamycin 50 μ g/ml; tetracycline 10 μ g/ml.
All antibiotics were purchased from Sigma-Aldrich (Sweden).
For determining growth curves, bacteria were incubated overnight in 2ml LB at 220 rpm in 37°C. The next, day 150μl of the culture was mixed with 850μl of PBS and the OD 600nm measured. The bacteria were then adjusted to an OD 600nm of 0.25 (Ultrospec 1000, Pharmacia Biotech). From this OD 600nm the bacteria were then diluted 1:25 in either LB or TY broth resulting in a final OD 600nm of 0.01. 400μl of this bacterial suspension was then loaded into wells in a Honeycomb Bioscreen plate (OY Growth Curves AB LTd, Helsinki, Finland) in three technical replicates. Uninoculated media was used as a negative growth control. The Bioscreen C plate reader (OY Growth Curves AB Ltd) was set to an OD of 600nm and optical density measurement was taken every 15 minutes with 5 seconds of agitation before every measurement, up until 24 hours.
PCR and oligonucleotides. Polymerase chain reaction (PCR) was performed using an Eppendorf Mastercycler Personal. Oligonucleotides were designed using the genome of S. Typhimurium LT2 as reference.
For the generation of the inserts for gene deletions the PCR was performed using Phusion High-Fidelitiy PCR master mix with HF buffer (New England Biolabs, USA). The cycling conditions were as following: 98°C for 1 min and 30 cycles of 98°C for 15 seconds, 54.5°C for 10 seconds, 72°C for 40 seconds, and 72°C for 2 minutes. The oligonucleotides were ordered from Sigma-Aldrich and specified in Table S2 .
For routine confirmatory PCR, Phusion High-Fidelitiy PCR master mix with HF buffer was used. The cycling conditions were as follows: 98°C for 1 minute and 30 cycles of 98°C for 15 seconds, annealing temperature for 10 seconds, 72°C for elongation time, and 72°C for 2 minutes. Annealing temperature varied depending on the primer pairs used, and elongation time was based on the length of the expected product (30 seconds per kilobase). Oligonucleotide sequences are shown in Table S2 .
Bacteriophage transduction. Phage P22int was that of Schmieger (Schmieger 1972) . Transducing phages were prepared on strain LB5010 (in LB broth supplemented with D-galactose (Fluka BioChemika) to 0.2% (wt/vol)) or strain 14028s carrying the mutation of interest. The next day chloroform was added to the culture and the culture was vortexed. The culture was then centrifuged for 10 minutes at 18500 g to create phase separation. The top phase was recovered and used to transfer the genetic marker. The transduction into S. Typhimurium SR-11 was done by incubating 20μl of the P22int phage containing the genetic marker with 1ml of exponential phase culture. These were incubated at 37°C with shaking at 220 rpm for 1 hour and after washing in PBS plated onto appropriate selective LB agar plates.
Construction and isolation of mutants. The antibiotic marker amplified from either pKD3 (Chl R ) or pKD4 (Kan R ) was conducted using primers with 3´-ends overlapping the borders of the gene to be deleted, and subsequently inserted into the chromosome, to replace the gene of interest, by double-stranded DNA lambda-red recombineering (Datsenko and Wanner 2000; Yu et al. 2000) . As recipients we used S. Typhimurium strain LB5010 containing the pSIM6, or S. Typhimurium strain 14028 containing pSIM5-tet plasmid, each grown to an OD 600nm of approximately 0.3 at 32°C with shaking at 220 rpm in a water bath.
To induce the lambda-red genes the bacteria were transferred to a 42°C water bath shaking at 220 rpm for 15 minutes. After cooling on ice for 10 minutes, bacterial cells were made electrocompetent by washing with ice-cold deionized water four times.
Electroporation of the PCR products generated from pKD3 or pKD4 was done using a Gene Pulser (Bio-Rad, USA) by mixing 25μl of electrocompetent cells and 0.5μl of purified PCR product, with settings 1.8 kV, 25 F and 200Ω. Cells were recovered in 1ml of LB at 32°C and 220 rpm for 2 hours. After recovery the culture was spun down and the pellet was spread on LB agar plates containing either chloramphenicol or kanamycin to select for recombinants. The genetic marker was subsequently transferred to wild type S. Typhimurium SR-11 by phage P22int transduction from either the LB5010 or 14028 mutant strains.
Antibiotic markers were removed from the mutants using the plasmid pCP20. Briefly, pCP20 was transferred by P22int transduction to the recipient strain containing the antibiotic marker, with selection for colonies on LB agar plates containing ampicillin. Transductants were subcultured three times at 28°C on selective LB agar plates. The bacteria were then subcultured three more times at 37°C to select for loss of plasmid and loss of antibiotic marker. The loss of the antibiotic marker was confirmed by a diagnostic PCR.
Isolation of vancomycin-tolerant Δ sprΔyebA mutants was conducted by spreading a LB broth culture of the Δ sprΔyebA mutant on a vancomycin gradient TY agar plate. In this, a plate of 14 cm in diameter was poured in a tilted position with 37.5ml of TY agar containing vancomycin at 40 μ g/ml. After solidification, 37.5ml TY agar lacking antibiotic was poured on top of the solidified TY agar containing vancomycin, now in a horizontal plane. The plate was seeded with about 10 7 CFU of Δ sprΔyebA mutant bacteria in their logarithmic growth phase. After 16 hours of incubation yielded colonies were isolated at the higher concentration end of the gradient.
Plasmid constructions and site-directed mutagenesis. For creating plasmids for genetic complementation, spr and tsp were PCR amplified using S. Typhimurium SR-11 genomic DNA as template, using oligonucleotide primers to create suitable restriction sites at each end of the amplified fragment. Enzymes used for restriction digestion were SacI or EcoRI, and HindIII (New England Biolabs) while T4 DNA ligase was used to ligate spr fragments into vector pBAD30 (Guzman et al. 1995) . Reaction buffers were provided by the enzyme supplier. Following ligation, plasmids were transformed (as above) into chemically competent E.coli TG1 or Top10 cells (Invitrogen) from where the constructs were purified and electroporated (as above) into S. Typhimurium LB5010. The plasmids were then transferred into S. Typhimurium SR-11 by P22int transduction.
Whole-genome sequencing and analysis. Genomic DNA was prepared from bacterial cultures using a Masterpure DNA Purification Kit (Epicentre). Libraries for sequencing were prepared using Nextera XT sample preparation and index kits (Illumina). The quality of libraries was assessed using a Tapestation 2200 (Agilent) with high-sensitivity D5000 Screentape. Sequencing of the libraries was done using a Miseq device (Illumina) using a 600-cycle V3 reagent kit. The sequences were processed and analyzed using CLC Genomics Workbench 9.0.1 (CLC bio).
Deoxycholate (DOC) sensitivity test.
To assay detergent sensitivity, bacteria were diluted 1:100 in LB from an overnight culture, and grown in LB for 2 hours at 37°C with shaking at 220 rpm. The OD 600nm of the culture was measured, and the formula ((0.484/OD 600nm ) x 2.1) used to adjust the amount of bacteria to obtain approximately 10 7 CFU/ml. The bacterial suspension was then diluted 1:100 in distilled water with sodium deoxycholate (DOC; Sigma-Aldrich, Sweden) freshly added to a final concentration of 0.5% (wt/vol). After an incubation of 30 minutes at room temperature, viable counts were determined from the DOCsuspension by plating dilutions on LB agar plates.
SDS-PAGE gel electrophoresis.
Polyacrylamide-bis-acrylamide gel electrophoresis was conducted according to Laemmli (Laemmli 1970) , using custom made a 12.5% separation (pH 8.8) and a 6% stacking gel (pH 6.8). (Thermo Scientific, Sweden) . For solubilisation, samples were suspended in reducing protein sample buffer (0.125 M Tris-HCl pH 6.5, 3.6% SDS, 10% β -mercaptoethanol, 2% glycerol, and bromphenol blue enough to give a deep blue color) and heated 10 minutes at 97°C before application on the gel. After completed electrophoresis, gels were stained using Imperial stain.
Bacterial membrane fractionation. The outer membrane fraction was isolated according to Sabet and Schnaitman (Sabet and Schnaitman 1973) . Bacteria from overnight LB cultures were diluted 1:100 into TY broth and grown at 37°C for 2 hours to mid exponential phase. The OD 600nm of the bacterial cultures were measured and then normalized. Bacteria were pelleted by centrifugation at 6000 g for 10 minutes, resuspended in PBS, cooled on ice, and disrupted by equal numbers of 10 seconds sonication pulses until the suspensions visibly cleared. Bacteria were removed by low-speed centrifugation (1500 g), after which the membrane fraction was pelleted by high-speed centrifugation (18500 g, 10 minutes). The waxy brownish pellet was then re-suspended in 50mM Tris-HCl buffer containing 10mM MgCl 2 and 0.5% Triton X-100. The membrane fraction was again pelleted by centrifugation (18500 g, 10 minutes), and the re-suspension and high-speed centrifugation steps were repeated. The final colourless pellet was then suspended in reducing protein sample buffer and run on a 12.5% according to Laemmli (Laemmli 1970) following by staining with Imperial stain (Thermo Scientific).
Disk diffusion sensitivity testing. Bacteria were grown overnight in LB broth at 37°C and 220 rpm. The overnight culture was diluted 1:100 in LB broth and grown for 2 hours at 37°C and 220 rpm. The OD 600nm was measured of the 2 hour culture and the formula ((0.484/OD 600nm ) x 2.1) was used to calculate the amount of bacteria needed for 10 6 CFU/ml. 3 x 10 5 CFU/ml bacteria were then spread on large (13.7 cm diameter) TY agar plates and the antibiotic disks were placed on top of the bacteria and the plates were incubated overnight at 37°C. The next day the diameters of the inhibitory zones were measured.
The disks, 6mm in diameter, were custom-made out of Whatman 3 paper, using an ordinary office paper puncher. Each disk then was infused with 5μl of an antibiotic, and then let to dry. Concentrations of the antibiotics used were; tetracycline 10 μ g/ml, vancomycin 20 μ g/ml, rifampicin 10 μ g/ml, polymyxin B 10 μ g/ml, novobiocin 10 μ g/ml, and penicillin G 10 μ g/ml (Sigma-Aldrich, Sweden). Every antibiotic was dissolved in water except rifampicin, which was dissolved in DMSO.
MIC determination.
Bacteria were grown overnight in LB broth at 37°C and 220 rpm. The overnight culture was diluted 1:100 in LB broth and grown for 2 hours at 37°C and 220 rpm. The OD 600nm was measured of the 2 hour culture and the formula ((0.484/OD 600nm ) x 2.1) was used to calculate the amount of bacteria needed for 2 x 10 4 CFU/ml in TY broth. This dilution was subsequently pipetted into a 96-well plate, containing TY broth with either vancomycin or penicillin G, resulting in a final concentration of 10 4 CFU/ml bacteria. The highest concentration for the vancomycin MIC testing was 100 μ g/ml and 50 μ g/ml for penicillin G. Then, the antibiotic was diluted down in steps of 1:2 from the highest concentration before an incubation over night at 37 o C.
Drop-on-lawn. Bacteria were grown overnight in LB broth at 37°C and 220 rpm. The overnight culture was diluted 1:100 in LB broth and grown for 2 hours at 37°C and 220 rpm. The OD 600nm was measured of the 2 hour culture and the formula ((0.484/OD 600nm ) x 2.1) was used to calculate the amount of bacteria needed for 10 6 CFU/ml. From 10 6 CFU/ml a 1:2 serial dilution series was made into 1ml PBS. From each dilution a 5μl droplet was pipetted onto TY agar plates containing none, 20 μ g/ml, or 40 μ g/ml vancomycin and the TY agar plates were incubated overnight at 37°C. For genetic complementation tests TY agar plates were supplemented with 0.02% (weight/vol) L-arabinose (Sigma-Aldrich, Sweden). β -galactosidase (LacZ) release assay. A phage lysate was prepared from LB5010 carrying pKTH3088 (Taira et al. 1991) , which is a pACYC184 derivative expressing the E.coli lacZ gene producing β galactosidase (Casadaban et al. 1983 ). This P22 lysate was used transfer the pKTH3088 to S. Typhimurium SR-11 strains. To assay for the release of β -galactosidase (LacZ), bacteria were grown overnight in LB broth at 37°C and 220 rpm. The overnight culture was diluted 1:100 in TY broth and grown for 2 hours at 37°C and 220 rpm to mid exponential phase. Following the incubation the OD 600nm of the culture was measured, where after 300μl of bacteria was added to 700μl TY broth containing different concentrations of penicillin G or vancomycin and incubated at 37°C for 60 minutes. When attempting to inhibit penicillin G and vancomycin induced autolysis, 20 μ g/ml tetracycline was added in this step. The bacteria were then pelleted by centrifuging and 200μl of the supernatant was transferred into a reaction tube containing 600μl reaction buffer (0.001M MgSO 4 and 0.05M β mercaptoethanol (Sigma-Aldrich, Sweden) in 0.01M PBS, pH 7.2), and 200μl of 4 mg/ml ONPG (Sigma-Aldrich, Sweden) dissolved in reaction buffer. The β -galactosidase activity was stopped at given time points by adding 500μl of 0.5M sodium carbonate. 1ml of the samples were transferred into cuvettes and the β -galactosidase activity was measured using OD 420nm . The formula to calculate the arbitrary units (AU) was implemented as according to Miller (Miller 1972) .
When measuring for the proportional and total β -galactosidase activities in the bacterial cells the samples were similarly incubated overnight and diluted 1:100 the next day for the 2 hour incubation. After the incubation the OD 600nm was measured and 300μl was added to 700μl of TY broth containing 40 μ g/ml penicillin G and incubated for 60 minutes at 37°C. The samples were pelleted by centrifugation and 200μl of the supernatant was added to 600μl of Z-buffer and 200μl of 4mg/ml ONPG in reaction buffer. In order to assay the amount of LacZ in the pellet, the rest of the supernatant was discarded and the pellet resuspended in 100μl TY broth. This suspension was added to 600μl of reaction buffer and 200μl of 4 mg/ml ONPG in reaction buffer supplemented with 50μl of 0.1% SDS (Sigma-Aldrich, Sweden) and 50μl of >99% chloroform (Sigma-Aldrich, Sweden) to allow for the ONPG to penetrate into the pelleted cells. The samples were then incubated at 30°C for 20 minutes, sodium carbonate was added, the OD 420nm was measured, and the calculations for the arbitrary units performed as above.
OD 600nm determination following antibiotic treatment. As a complement to the β -galactosidase release assay we followed alterations in OD 600nm for the same strains. The strains were grown as above in that the bacteria were grown overnight in LB broth at 37°C and 220 rpm. The overnight culture was diluted 1:100 in TY broth and grown for 2 hours at 37°C and 220 rpm to mid exponential phase. Following the incubation the OD 600nm of the culture was measured as the "pre-value". Simultaneously, 300μl of bacteria was added to 700μl TY broth containing different concentrations of vancomycin or penicillin G and incubated at 37°C for 60 minutes. Following this incubation the OD 600nm was measured as the "post-value". To visualize the effect of the antibiotics on the OD 600nm the post-values were divided with the prevalues.
Viable count from broth. Also as a complement to the β -galactosidase release assays we determined the viable count for each strain at the highest concentration of vancomycin (200 μ g/ml) and penicillin G (40 μ g/ml). The strains were grown as above in that the bacteria were grown overnight in LB broth at 37°C and 220 rpm. The overnight culture was diluted 1:100 in TY broth and grown for 2 hours at 37°C and 220 rpm to mid exponential phase. Following the incubation the viable count for the input was enumerated by taking 300μl of bacteria into 700μl TY broth and a 1:10 serial dilution was performed in PBS. Bacteria were then spread on LB agar plates and incubated overnight at 37°C and the CFU were counted the next day, yielding the input value. In parallel 300μl of bacteria was added to 700μl TY broth containing either penicillin G or vancomycin and incubated at 37°C for 60 minutes. Following this incubation the strains were serially diluted 1:10 in PBS and the bacteria were then spread on LB agar plates and incubated overnight at 37°C and the CFU was counted the next day, yielding the output value.
Statistical analysis. GraphPad Prism v6.0g (GraphPad Software, Inc., USA) was used for statistical analysis.
